Global Spine Biologics Market Size, Status and Forecast 2020-2026
Spine biologics are used in spine surgery as lieu allografts and as support for bones in and around the spinal region. They can also be used as products that can cure the spine injuries or disorders or degenerated discs.
North America region is the largest supplier of Spine Biologics, with a production market share nearly 63%. Europe is the second largest supplier of Spine Biologics, enjoying production market share nearly 28%.
North America is the largest consumption place, with a consumption market share nearly 61%. Following North America, Europe is the second largest consumption place with the consumption market share of 21%.
Market competition is not intense. Medtronic, Depuy Synthes, Stryker Corporation, Nuvasive and Zimmer Biomet etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers, have been formed in the monopoly position in the industry. The Market Share of Medtronic is 40% in 2015.
With the development of medical technology level, more and more companies participate in this industry. For example, Spine Biologics of EnteroMedics and Inspire Medical have been approved by FDA in 2015.
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Spine Biologics market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Spine Biologics industry.
Based on our recent survey, we have several different scenarios about the Spine Biologics YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ 2214.8 million in 2019. The market size of Spine Biologics will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Spine Biologics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Spine Biologics market in terms of revenue.
Players, stakeholders, and other participants in the global Spine Biologics market will be able to gain the upper hand as they use the report as a powerful resource. For this version of the report, the segmental analysis focuses on revenue and forecast by each application segment in terms of revenue and forecast by each type segment in terms of revenue for the period 2015-2026.
Regional and Country-level Analysis
The report offers an exhaustive geographical analysis of the global Spine Biologics market, covering important regions, viz, North America, Europe, China, Japan, Southeast Asia, India and Central & South America. It also covers key countries (regions), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, UAE, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by each application segment in terms of revenue for the period 2015-2026.
Competition Analysis
In the competitive analysis section of the report, leading as well as prominent players of the global Spine Biologics market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Spine Biologics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Spine Biologics market.
The following players are covered in this report:
North America region is the largest supplier of Spine Biologics, with a production market share nearly 63%. Europe is the second largest supplier of Spine Biologics, enjoying production market share nearly 28%.
North America is the largest consumption place, with a consumption market share nearly 61%. Following North America, Europe is the second largest consumption place with the consumption market share of 21%.
Market competition is not intense. Medtronic, Depuy Synthes, Stryker Corporation, Nuvasive and Zimmer Biomet etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers, have been formed in the monopoly position in the industry. The Market Share of Medtronic is 40% in 2015.
With the development of medical technology level, more and more companies participate in this industry. For example, Spine Biologics of EnteroMedics and Inspire Medical have been approved by FDA in 2015.
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Spine Biologics market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Spine Biologics industry.
Based on our recent survey, we have several different scenarios about the Spine Biologics YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ 2214.8 million in 2019. The market size of Spine Biologics will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Spine Biologics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Spine Biologics market in terms of revenue.
Players, stakeholders, and other participants in the global Spine Biologics market will be able to gain the upper hand as they use the report as a powerful resource. For this version of the report, the segmental analysis focuses on revenue and forecast by each application segment in terms of revenue and forecast by each type segment in terms of revenue for the period 2015-2026.
Regional and Country-level Analysis
The report offers an exhaustive geographical analysis of the global Spine Biologics market, covering important regions, viz, North America, Europe, China, Japan, Southeast Asia, India and Central & South America. It also covers key countries (regions), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, UAE, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by each application segment in terms of revenue for the period 2015-2026.
Competition Analysis
In the competitive analysis section of the report, leading as well as prominent players of the global Spine Biologics market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Spine Biologics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Spine Biologics market.
The following players are covered in this report:
- Medtronic
- Depuy Synthes
- Stryker Corporation
- Nuvasive
- Zimmer Biomet
- Orthofix International
- Globus Medical
- alphatec spine
- K2M
- Exactech
- Wright Medical Technology
- X-Spine
- Nutech
- Arthrex
- Bone Graft
- Bone Graft Substitute
- Platelet Rich Plasma (PRP)
- BMAC (Bone Marrow Aspirate Concentrate)
- Anterior Cervical Discectomy and Fusion
- Posterior Lumbar Interbody Fusion
- Other
1 REPORT OVERVIEW
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Spine Biologics Revenue
1.4 Market Analysis by Type
1.4.1 Global Spine Biologics Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Bone Graft
1.4.3 Bone Graft Substitute
1.4.4 Platelet Rich Plasma (PRP)
1.4.5 BMAC (Bone Marrow Aspirate Concentrate)
1.5 Market by Application
1.5.1 Global Spine Biologics Market Share by Application: 2020 VS 2026
1.5.2 Anterior Cervical Discectomy and Fusion
1.5.3 Posterior Lumbar Interbody Fusion
1.5.4 Other
1.6 Coronavirus Disease 2019 (Covid-19): Spine Biologics Industry Impact
1.6.1 How the Covid-19 is Affecting the Spine Biologics Industry
1.6.1.1 Spine Biologics Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Spine Biologics Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Spine Biologics Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 GLOBAL GROWTH TRENDS BY REGIONS
2.1 Spine Biologics Market Perspective (2015-2026)
2.2 Spine Biologics Growth Trends by Regions
2.2.1 Spine Biologics Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Spine Biologics Historic Market Share by Regions (2015-2020)
2.2.3 Spine Biologics Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Spine Biologics Market Growth Strategy
2.3.6 Primary Interviews with Key Spine Biologics Players (Opinion Leaders)
3 COMPETITION LANDSCAPE BY KEY PLAYERS
3.1 Global Top Spine Biologics Players by Market Size
3.1.1 Global Top Spine Biologics Players by Revenue (2015-2020)
3.1.2 Global Spine Biologics Revenue Market Share by Players (2015-2020)
3.1.3 Global Spine Biologics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Spine Biologics Market Concentration Ratio
3.2.1 Global Spine Biologics Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Spine Biologics Revenue in 2019
3.3 Spine Biologics Key Players Head office and Area Served
3.4 Key Players Spine Biologics Product Solution and Service
3.5 Date of Enter into Spine Biologics Market
3.6 Mergers & Acquisitions, Expansion Plans
4 BREAKDOWN DATA BY TYPE (2015-2026)
4.1 Global Spine Biologics Historic Market Size by Type (2015-2020)
4.2 Global Spine Biologics Forecasted Market Size by Type (2021-2026)
5 SPINE BIOLOGICS BREAKDOWN DATA BY APPLICATION (2015-2026)
5.1 Global Spine Biologics Market Size by Application (2015-2020)
5.2 Global Spine Biologics Forecasted Market Size by Application (2021-2026)
6 NORTH AMERICA
6.1 North America Spine Biologics Market Size (2015-2020)
6.2 Spine Biologics Key Players in North America (2019-2020)
6.3 North America Spine Biologics Market Size by Type (2015-2020)
6.4 North America Spine Biologics Market Size by Application (2015-2020)
7 EUROPE
7.1 Europe Spine Biologics Market Size (2015-2020)
7.2 Spine Biologics Key Players in Europe (2019-2020)
7.3 Europe Spine Biologics Market Size by Type (2015-2020)
7.4 Europe Spine Biologics Market Size by Application (2015-2020)
8 CHINA
8.1 China Spine Biologics Market Size (2015-2020)
8.2 Spine Biologics Key Players in China (2019-2020)
8.3 China Spine Biologics Market Size by Type (2015-2020)
8.4 China Spine Biologics Market Size by Application (2015-2020)
9 JAPAN
9.1 Japan Spine Biologics Market Size (2015-2020)
9.2 Spine Biologics Key Players in Japan (2019-2020)
9.3 Japan Spine Biologics Market Size by Type (2015-2020)
9.4 Japan Spine Biologics Market Size by Application (2015-2020)
10 SOUTHEAST ASIA
10.1 Southeast Asia Spine Biologics Market Size (2015-2020)
10.2 Spine Biologics Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Spine Biologics Market Size by Type (2015-2020)
10.4 Southeast Asia Spine Biologics Market Size by Application (2015-2020)
11 INDIA
11.1 India Spine Biologics Market Size (2015-2020)
11.2 Spine Biologics Key Players in India (2019-2020)
11.3 India Spine Biologics Market Size by Type (2015-2020)
11.4 India Spine Biologics Market Size by Application (2015-2020)
12 CENTRAL & SOUTH AMERICA
12.1 Central & South America Spine Biologics Market Size (2015-2020)
12.2 Spine Biologics Key Players in Central & South America (2019-2020)
12.3 Central & South America Spine Biologics Market Size by Type (2015-2020)
12.4 Central & South America Spine Biologics Market Size by Application (2015-2020)
13 KEY PLAYERS PROFILES
13.1 Medtronic
13.1.1 Medtronic Company Details
13.1.2 Medtronic Business Overview and Its Total Revenue
13.1.3 Medtronic Spine Biologics Introduction
13.1.4 Medtronic Revenue in Spine Biologics Business (2015-2020))
13.1.5 Medtronic Recent Development
13.2 Depuy Synthes
13.2.1 Depuy Synthes Company Details
13.2.2 Depuy Synthes Business Overview and Its Total Revenue
13.2.3 Depuy Synthes Spine Biologics Introduction
13.2.4 Depuy Synthes Revenue in Spine Biologics Business (2015-2020)
13.2.5 Depuy Synthes Recent Development
13.3 Stryker Corporation
13.3.1 Stryker Corporation Company Details
13.3.2 Stryker Corporation Business Overview and Its Total Revenue
13.3.3 Stryker Corporation Spine Biologics Introduction
13.3.4 Stryker Corporation Revenue in Spine Biologics Business (2015-2020)
13.3.5 Stryker Corporation Recent Development
13.4 Nuvasive
13.4.1 Nuvasive Company Details
13.4.2 Nuvasive Business Overview and Its Total Revenue
13.4.3 Nuvasive Spine Biologics Introduction
13.4.4 Nuvasive Revenue in Spine Biologics Business (2015-2020)
13.4.5 Nuvasive Recent Development
13.5 Zimmer Biomet
13.5.1 Zimmer Biomet Company Details
13.5.2 Zimmer Biomet Business Overview and Its Total Revenue
13.5.3 Zimmer Biomet Spine Biologics Introduction
13.5.4 Zimmer Biomet Revenue in Spine Biologics Business (2015-2020)
13.5.5 Zimmer Biomet Recent Development
13.6 Orthofix International
13.6.1 Orthofix International Company Details
13.6.2 Orthofix International Business Overview and Its Total Revenue
13.6.3 Orthofix International Spine Biologics Introduction
13.6.4 Orthofix International Revenue in Spine Biologics Business (2015-2020)
13.6.5 Orthofix International Recent Development
13.7 Globus Medical
13.7.1 Globus Medical Company Details
13.7.2 Globus Medical Business Overview and Its Total Revenue
13.7.3 Globus Medical Spine Biologics Introduction
13.7.4 Globus Medical Revenue in Spine Biologics Business (2015-2020)
13.7.5 Globus Medical Recent Development
13.8 alphatec spine
13.8.1 alphatec spine Company Details
13.8.2 alphatec spine Business Overview and Its Total Revenue
13.8.3 alphatec spine Spine Biologics Introduction
13.8.4 alphatec spine Revenue in Spine Biologics Business (2015-2020)
13.8.5 alphatec spine Recent Development
13.9 K2M
13.9.1 K2M Company Details
13.9.2 K2M Business Overview and Its Total Revenue
13.9.3 K2M Spine Biologics Introduction
13.9.4 K2M Revenue in Spine Biologics Business (2015-2020)
13.9.5 K2M Recent Development
13.10 Exactech
13.10.1 Exactech Company Details
13.10.2 Exactech Business Overview and Its Total Revenue
13.10.3 Exactech Spine Biologics Introduction
13.10.4 Exactech Revenue in Spine Biologics Business (2015-2020)
13.10.5 Exactech Recent Development
13.11 Wright Medical Technology
10.11.1 Wright Medical Technology Company Details
10.11.2 Wright Medical Technology Business Overview and Its Total Revenue
10.11.3 Wright Medical Technology Spine Biologics Introduction
10.11.4 Wright Medical Technology Revenue in Spine Biologics Business (2015-2020)
10.11.5 Wright Medical Technology Recent Development
13.12 X-Spine
10.12.1 X-Spine Company Details
10.12.2 X-Spine Business Overview and Its Total Revenue
10.12.3 X-Spine Spine Biologics Introduction
10.12.4 X-Spine Revenue in Spine Biologics Business (2015-2020)
10.12.5 X-Spine Recent Development
13.13 Nutech
10.13.1 Nutech Company Details
10.13.2 Nutech Business Overview and Its Total Revenue
10.13.3 Nutech Spine Biologics Introduction
10.13.4 Nutech Revenue in Spine Biologics Business (2015-2020)
10.13.5 Nutech Recent Development
13.14 Arthrex
10.14.1 Arthrex Company Details
10.14.2 Arthrex Business Overview and Its Total Revenue
10.14.3 Arthrex Spine Biologics Introduction
10.14.4 Arthrex Revenue in Spine Biologics Business (2015-2020)
10.14.5 Arthrex Recent Development
14 ANALYST'S VIEWPOINTS/CONCLUSIONS
15 APPENDIX
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Spine Biologics Revenue
1.4 Market Analysis by Type
1.4.1 Global Spine Biologics Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Bone Graft
1.4.3 Bone Graft Substitute
1.4.4 Platelet Rich Plasma (PRP)
1.4.5 BMAC (Bone Marrow Aspirate Concentrate)
1.5 Market by Application
1.5.1 Global Spine Biologics Market Share by Application: 2020 VS 2026
1.5.2 Anterior Cervical Discectomy and Fusion
1.5.3 Posterior Lumbar Interbody Fusion
1.5.4 Other
1.6 Coronavirus Disease 2019 (Covid-19): Spine Biologics Industry Impact
1.6.1 How the Covid-19 is Affecting the Spine Biologics Industry
1.6.1.1 Spine Biologics Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Spine Biologics Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Spine Biologics Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 GLOBAL GROWTH TRENDS BY REGIONS
2.1 Spine Biologics Market Perspective (2015-2026)
2.2 Spine Biologics Growth Trends by Regions
2.2.1 Spine Biologics Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Spine Biologics Historic Market Share by Regions (2015-2020)
2.2.3 Spine Biologics Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Spine Biologics Market Growth Strategy
2.3.6 Primary Interviews with Key Spine Biologics Players (Opinion Leaders)
3 COMPETITION LANDSCAPE BY KEY PLAYERS
3.1 Global Top Spine Biologics Players by Market Size
3.1.1 Global Top Spine Biologics Players by Revenue (2015-2020)
3.1.2 Global Spine Biologics Revenue Market Share by Players (2015-2020)
3.1.3 Global Spine Biologics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Spine Biologics Market Concentration Ratio
3.2.1 Global Spine Biologics Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Spine Biologics Revenue in 2019
3.3 Spine Biologics Key Players Head office and Area Served
3.4 Key Players Spine Biologics Product Solution and Service
3.5 Date of Enter into Spine Biologics Market
3.6 Mergers & Acquisitions, Expansion Plans
4 BREAKDOWN DATA BY TYPE (2015-2026)
4.1 Global Spine Biologics Historic Market Size by Type (2015-2020)
4.2 Global Spine Biologics Forecasted Market Size by Type (2021-2026)
5 SPINE BIOLOGICS BREAKDOWN DATA BY APPLICATION (2015-2026)
5.1 Global Spine Biologics Market Size by Application (2015-2020)
5.2 Global Spine Biologics Forecasted Market Size by Application (2021-2026)
6 NORTH AMERICA
6.1 North America Spine Biologics Market Size (2015-2020)
6.2 Spine Biologics Key Players in North America (2019-2020)
6.3 North America Spine Biologics Market Size by Type (2015-2020)
6.4 North America Spine Biologics Market Size by Application (2015-2020)
7 EUROPE
7.1 Europe Spine Biologics Market Size (2015-2020)
7.2 Spine Biologics Key Players in Europe (2019-2020)
7.3 Europe Spine Biologics Market Size by Type (2015-2020)
7.4 Europe Spine Biologics Market Size by Application (2015-2020)
8 CHINA
8.1 China Spine Biologics Market Size (2015-2020)
8.2 Spine Biologics Key Players in China (2019-2020)
8.3 China Spine Biologics Market Size by Type (2015-2020)
8.4 China Spine Biologics Market Size by Application (2015-2020)
9 JAPAN
9.1 Japan Spine Biologics Market Size (2015-2020)
9.2 Spine Biologics Key Players in Japan (2019-2020)
9.3 Japan Spine Biologics Market Size by Type (2015-2020)
9.4 Japan Spine Biologics Market Size by Application (2015-2020)
10 SOUTHEAST ASIA
10.1 Southeast Asia Spine Biologics Market Size (2015-2020)
10.2 Spine Biologics Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Spine Biologics Market Size by Type (2015-2020)
10.4 Southeast Asia Spine Biologics Market Size by Application (2015-2020)
11 INDIA
11.1 India Spine Biologics Market Size (2015-2020)
11.2 Spine Biologics Key Players in India (2019-2020)
11.3 India Spine Biologics Market Size by Type (2015-2020)
11.4 India Spine Biologics Market Size by Application (2015-2020)
12 CENTRAL & SOUTH AMERICA
12.1 Central & South America Spine Biologics Market Size (2015-2020)
12.2 Spine Biologics Key Players in Central & South America (2019-2020)
12.3 Central & South America Spine Biologics Market Size by Type (2015-2020)
12.4 Central & South America Spine Biologics Market Size by Application (2015-2020)
13 KEY PLAYERS PROFILES
13.1 Medtronic
13.1.1 Medtronic Company Details
13.1.2 Medtronic Business Overview and Its Total Revenue
13.1.3 Medtronic Spine Biologics Introduction
13.1.4 Medtronic Revenue in Spine Biologics Business (2015-2020))
13.1.5 Medtronic Recent Development
13.2 Depuy Synthes
13.2.1 Depuy Synthes Company Details
13.2.2 Depuy Synthes Business Overview and Its Total Revenue
13.2.3 Depuy Synthes Spine Biologics Introduction
13.2.4 Depuy Synthes Revenue in Spine Biologics Business (2015-2020)
13.2.5 Depuy Synthes Recent Development
13.3 Stryker Corporation
13.3.1 Stryker Corporation Company Details
13.3.2 Stryker Corporation Business Overview and Its Total Revenue
13.3.3 Stryker Corporation Spine Biologics Introduction
13.3.4 Stryker Corporation Revenue in Spine Biologics Business (2015-2020)
13.3.5 Stryker Corporation Recent Development
13.4 Nuvasive
13.4.1 Nuvasive Company Details
13.4.2 Nuvasive Business Overview and Its Total Revenue
13.4.3 Nuvasive Spine Biologics Introduction
13.4.4 Nuvasive Revenue in Spine Biologics Business (2015-2020)
13.4.5 Nuvasive Recent Development
13.5 Zimmer Biomet
13.5.1 Zimmer Biomet Company Details
13.5.2 Zimmer Biomet Business Overview and Its Total Revenue
13.5.3 Zimmer Biomet Spine Biologics Introduction
13.5.4 Zimmer Biomet Revenue in Spine Biologics Business (2015-2020)
13.5.5 Zimmer Biomet Recent Development
13.6 Orthofix International
13.6.1 Orthofix International Company Details
13.6.2 Orthofix International Business Overview and Its Total Revenue
13.6.3 Orthofix International Spine Biologics Introduction
13.6.4 Orthofix International Revenue in Spine Biologics Business (2015-2020)
13.6.5 Orthofix International Recent Development
13.7 Globus Medical
13.7.1 Globus Medical Company Details
13.7.2 Globus Medical Business Overview and Its Total Revenue
13.7.3 Globus Medical Spine Biologics Introduction
13.7.4 Globus Medical Revenue in Spine Biologics Business (2015-2020)
13.7.5 Globus Medical Recent Development
13.8 alphatec spine
13.8.1 alphatec spine Company Details
13.8.2 alphatec spine Business Overview and Its Total Revenue
13.8.3 alphatec spine Spine Biologics Introduction
13.8.4 alphatec spine Revenue in Spine Biologics Business (2015-2020)
13.8.5 alphatec spine Recent Development
13.9 K2M
13.9.1 K2M Company Details
13.9.2 K2M Business Overview and Its Total Revenue
13.9.3 K2M Spine Biologics Introduction
13.9.4 K2M Revenue in Spine Biologics Business (2015-2020)
13.9.5 K2M Recent Development
13.10 Exactech
13.10.1 Exactech Company Details
13.10.2 Exactech Business Overview and Its Total Revenue
13.10.3 Exactech Spine Biologics Introduction
13.10.4 Exactech Revenue in Spine Biologics Business (2015-2020)
13.10.5 Exactech Recent Development
13.11 Wright Medical Technology
10.11.1 Wright Medical Technology Company Details
10.11.2 Wright Medical Technology Business Overview and Its Total Revenue
10.11.3 Wright Medical Technology Spine Biologics Introduction
10.11.4 Wright Medical Technology Revenue in Spine Biologics Business (2015-2020)
10.11.5 Wright Medical Technology Recent Development
13.12 X-Spine
10.12.1 X-Spine Company Details
10.12.2 X-Spine Business Overview and Its Total Revenue
10.12.3 X-Spine Spine Biologics Introduction
10.12.4 X-Spine Revenue in Spine Biologics Business (2015-2020)
10.12.5 X-Spine Recent Development
13.13 Nutech
10.13.1 Nutech Company Details
10.13.2 Nutech Business Overview and Its Total Revenue
10.13.3 Nutech Spine Biologics Introduction
10.13.4 Nutech Revenue in Spine Biologics Business (2015-2020)
10.13.5 Nutech Recent Development
13.14 Arthrex
10.14.1 Arthrex Company Details
10.14.2 Arthrex Business Overview and Its Total Revenue
10.14.3 Arthrex Spine Biologics Introduction
10.14.4 Arthrex Revenue in Spine Biologics Business (2015-2020)
10.14.5 Arthrex Recent Development
14 ANALYST'S VIEWPOINTS/CONCLUSIONS
15 APPENDIX
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
LIST OF TABLES
Table 1. Spine Biologics Key Market Segments
Table 2. Key Players Covered: Ranking by Spine Biologics Revenue
Table 3. Ranking of Global Top Spine Biologics Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Spine Biologics Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Bone Graft
Table 6. Key Players of Bone Graft Substitute
Table 7. Key Players of Platelet Rich Plasma (PRP)
Table 8. Key Players of BMAC (Bone Marrow Aspirate Concentrate)
Table 9. COVID-19 Impact Global Market: (Four Spine Biologics Market Size Forecast Scenarios)
Table 10. Opportunities and Trends for Spine Biologics Players in the COVID-19 Landscape
Table 11. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 12. Key Regions/Countries Measures against Covid-19 Impact
Table 13. Proposal for Spine Biologics Players to Combat Covid-19 Impact
Table 14. Global Spine Biologics Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 15. Global Spine Biologics Market Size by Regions (US$ Million): 2020 VS 2026
Table 16. Global Spine Biologics Market Size by Regions (2015-2020) (US$ Million)
Table 17. Global Spine Biologics Market Share by Regions (2015-2020)
Table 18. Global Spine Biologics Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 19. Global Spine Biologics Market Share by Regions (2021-2026)
Table 20. Market Top Trends
Table 21. Key Drivers: Impact Analysis
Table 22. Key Challenges
Table 23. Spine Biologics Market Growth Strategy
Table 24. Main Points Interviewed from Key Spine Biologics Players
Table 25. Global Spine Biologics Revenue by Players (2015-2020) (Million US$)
Table 26. Global Spine Biologics Market Share by Players (2015-2020)
Table 27. Global Top Spine Biologics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Spine Biologics as of 2019)
Table 28. Global Spine Biologics by Players Market Concentration Ratio (CR5 and HHI)
Table 29. Key Players Headquarters and Area Served
Table 30. Key Players Spine Biologics Product Solution and Service
Table 31. Date of Enter into Spine Biologics Market
Table 32. Mergers & Acquisitions, Expansion Plans
Table 33. Global Spine Biologics Market Size by Type (2015-2020) (Million US$)
Table 34. Global Spine Biologics Market Size Share by Type (2015-2020)
Table 35. Global Spine Biologics Revenue Market Share by Type (2021-2026)
Table 36. Global Spine Biologics Market Size Share by Application (2015-2020)
Table 37. Global Spine Biologics Market Size by Application (2015-2020) (Million US$)
Table 38. Global Spine Biologics Market Size Share by Application (2021-2026)
Table 39. North America Key Players Spine Biologics Revenue (2019-2020) (Million US$)
Table 40. North America Key Players Spine Biologics Market Share (2019-2020)
Table 41. North America Spine Biologics Market Size by Type (2015-2020) (Million US$)
Table 42. North America Spine Biologics Market Share by Type (2015-2020)
Table 43. North America Spine Biologics Market Size by Application (2015-2020) (Million US$)
Table 44. North America Spine Biologics Market Share by Application (2015-2020)
Table 45. Europe Key Players Spine Biologics Revenue (2019-2020) (Million US$)
Table 46. Europe Key Players Spine Biologics Market Share (2019-2020)
Table 47. Europe Spine Biologics Market Size by Type (2015-2020) (Million US$)
Table 48. Europe Spine Biologics Market Share by Type (2015-2020)
Table 49. Europe Spine Biologics Market Size by Application (2015-2020) (Million US$)
Table 50. Europe Spine Biologics Market Share by Application (2015-2020)
Table 51. China Key Players Spine Biologics Revenue (2019-2020) (Million US$)
Table 52. China Key Players Spine Biologics Market Share (2019-2020)
Table 53. China Spine Biologics Market Size by Type (2015-2020) (Million US$)
Table 54. China Spine Biologics Market Share by Type (2015-2020)
Table 55. China Spine Biologics Market Size by Application (2015-2020) (Million US$)
Table 56. China Spine Biologics Market Share by Application (2015-2020)
Table 57. Japan Key Players Spine Biologics Revenue (2019-2020) (Million US$)
Table 58. Japan Key Players Spine Biologics Market Share (2019-2020)
Table 59. Japan Spine Biologics Market Size by Type (2015-2020) (Million US$)
Table 60. Japan Spine Biologics Market Share by Type (2015-2020)
Table 61. Japan Spine Biologics Market Size by Application (2015-2020) (Million US$)
Table 62. Japan Spine Biologics Market Share by Application (2015-2020)
Table 63. Southeast Asia Key Players Spine Biologics Revenue (2019-2020) (Million US$)
Table 64. Southeast Asia Key Players Spine Biologics Market Share (2019-2020)
Table 65. Southeast Asia Spine Biologics Market Size by Type (2015-2020) (Million US$)
Table 66. Southeast Asia Spine Biologics Market Share by Type (2015-2020)
Table 67. Southeast Asia Spine Biologics Market Size by Application (2015-2020) (Million US$)
Table 68. Southeast Asia Spine Biologics Market Share by Application (2015-2020)
Table 69. India Key Players Spine Biologics Revenue (2019-2020) (Million US$)
Table 70. India Key Players Spine Biologics Market Share (2019-2020)
Table 71. India Spine Biologics Market Size by Type (2015-2020) (Million US$)
Table 72. India Spine Biologics Market Share by Type (2015-2020)
Table 73. India Spine Biologics Market Size by Application (2015-2020) (Million US$)
Table 74. India Spine Biologics Market Share by Application (2015-2020)
Table 75. Central & South America Key Players Spine Biologics Revenue (2019-2020) (Million US$)
Table 76. Central & South America Key Players Spine Biologics Market Share (2019-2020)
Table 77. Central & South America Spine Biologics Market Size by Type (2015-2020) (Million US$)
Table 78. Central & South America Spine Biologics Market Share by Type (2015-2020)
Table 79. Central & South America Spine Biologics Market Size by Application (2015-2020) (Million US$)
Table 80. Central & South America Spine Biologics Market Share by Application (2015-2020)
Table 81. Medtronic Company Details
Table 82. Medtronic Business Overview
Table 83. Medtronic Product
Table 84. Medtronic Revenue in Spine Biologics Business (2015-2020) (Million US$)
Table 85. Medtronic Recent Development
Table 86. Depuy Synthes Company Details
Table 87. Depuy Synthes Business Overview
Table 88. Depuy Synthes Product
Table 89. Depuy Synthes Revenue in Spine Biologics Business (2015-2020) (Million US$)
Table 90. Depuy Synthes Recent Development
Table 91. Stryker Corporation Company Details
Table 92. Stryker Corporation Business Overview
Table 93. Stryker Corporation Product
Table 94. Stryker Corporation Revenue in Spine Biologics Business (2015-2020) (Million US$)
Table 95. Stryker Corporation Recent Development
Table 96. Nuvasive Company Details
Table 97. Nuvasive Business Overview
Table 98. Nuvasive Product
Table 99. Nuvasive Revenue in Spine Biologics Business (2015-2020) (Million US$)
Table 100. Nuvasive Recent Development
Table 101. Zimmer Biomet Company Details
Table 102. Zimmer Biomet Business Overview
Table 103. Zimmer Biomet Product
Table 104. Zimmer Biomet Revenue in Spine Biologics Business (2015-2020) (Million US$)
Table 105. Zimmer Biomet Recent Development
Table 106. Orthofix International Company Details
Table 107. Orthofix International Business Overview
Table 108. Orthofix International Product
Table 109. Orthofix International Revenue in Spine Biologics Business (2015-2020) (Million US$)
Table 110. Orthofix International Recent Development
Table 111. Globus Medical Company Details
Table 112. Globus Medical Business Overview
Table 113. Globus Medical Product
Table 114. Globus Medical Revenue in Spine Biologics Business (2015-2020) (Million US$)
Table 115. Globus Medical Recent Development
Table 116. alphatec spine Business Overview
Table 117. alphatec spine Product
Table 118. alphatec spine Company Details
Table 119. alphatec spine Revenue in Spine Biologics Business (2015-2020) (Million US$)
Table 120. alphatec spine Recent Development
Table 121. K2M Company Details
Table 122. K2M Business Overview
Table 123. K2M Product
Table 124. K2M Revenue in Spine Biologics Business (2015-2020) (Million US$)
Table 125. K2M Recent Development
Table 126. Exactech Company Details
Table 127. Exactech Business Overview
Table 128. Exactech Product
Table 129. Exactech Revenue in Spine Biologics Business (2015-2020) (Million US$)
Table 130. Exactech Recent Development
Table 131. Wright Medical Technology Company Details
Table 132. Wright Medical Technology Business Overview
Table 133. Wright Medical Technology Product
Table 134. Wright Medical Technology Revenue in Spine Biologics Business (2015-2020) (Million US$)
Table 135. Wright Medical Technology Recent Development
Table 136. X-Spine Company Details
Table 137. X-Spine Business Overview
Table 138. X-Spine Product
Table 139. X-Spine Revenue in Spine Biologics Business (2015-2020) (Million US$)
Table 140. X-Spine Recent Development
Table 141. Nutech Company Details
Table 142. Nutech Business Overview
Table 143. Nutech Product
Table 144. Nutech Revenue in Spine Biologics Business (2015-2020) (Million US$)
Table 145. Nutech Recent Development
Table 146. Arthrex Company Details
Table 147. Arthrex Business Overview
Table 148. Arthrex Product
Table 149. Arthrex Revenue in Spine Biologics Business (2015-2020) (Million US$)
Table 150. Arthrex Recent Development
Table 151. Research Programs/Design for This Report
Table 152. Key Data Information from Secondary Sources
Table 153. Key Data Information from Primary Sources
Table 1. Spine Biologics Key Market Segments
Table 2. Key Players Covered: Ranking by Spine Biologics Revenue
Table 3. Ranking of Global Top Spine Biologics Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Spine Biologics Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Bone Graft
Table 6. Key Players of Bone Graft Substitute
Table 7. Key Players of Platelet Rich Plasma (PRP)
Table 8. Key Players of BMAC (Bone Marrow Aspirate Concentrate)
Table 9. COVID-19 Impact Global Market: (Four Spine Biologics Market Size Forecast Scenarios)
Table 10. Opportunities and Trends for Spine Biologics Players in the COVID-19 Landscape
Table 11. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 12. Key Regions/Countries Measures against Covid-19 Impact
Table 13. Proposal for Spine Biologics Players to Combat Covid-19 Impact
Table 14. Global Spine Biologics Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 15. Global Spine Biologics Market Size by Regions (US$ Million): 2020 VS 2026
Table 16. Global Spine Biologics Market Size by Regions (2015-2020) (US$ Million)
Table 17. Global Spine Biologics Market Share by Regions (2015-2020)
Table 18. Global Spine Biologics Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 19. Global Spine Biologics Market Share by Regions (2021-2026)
Table 20. Market Top Trends
Table 21. Key Drivers: Impact Analysis
Table 22. Key Challenges
Table 23. Spine Biologics Market Growth Strategy
Table 24. Main Points Interviewed from Key Spine Biologics Players
Table 25. Global Spine Biologics Revenue by Players (2015-2020) (Million US$)
Table 26. Global Spine Biologics Market Share by Players (2015-2020)
Table 27. Global Top Spine Biologics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Spine Biologics as of 2019)
Table 28. Global Spine Biologics by Players Market Concentration Ratio (CR5 and HHI)
Table 29. Key Players Headquarters and Area Served
Table 30. Key Players Spine Biologics Product Solution and Service
Table 31. Date of Enter into Spine Biologics Market
Table 32. Mergers & Acquisitions, Expansion Plans
Table 33. Global Spine Biologics Market Size by Type (2015-2020) (Million US$)
Table 34. Global Spine Biologics Market Size Share by Type (2015-2020)
Table 35. Global Spine Biologics Revenue Market Share by Type (2021-2026)
Table 36. Global Spine Biologics Market Size Share by Application (2015-2020)
Table 37. Global Spine Biologics Market Size by Application (2015-2020) (Million US$)
Table 38. Global Spine Biologics Market Size Share by Application (2021-2026)
Table 39. North America Key Players Spine Biologics Revenue (2019-2020) (Million US$)
Table 40. North America Key Players Spine Biologics Market Share (2019-2020)
Table 41. North America Spine Biologics Market Size by Type (2015-2020) (Million US$)
Table 42. North America Spine Biologics Market Share by Type (2015-2020)
Table 43. North America Spine Biologics Market Size by Application (2015-2020) (Million US$)
Table 44. North America Spine Biologics Market Share by Application (2015-2020)
Table 45. Europe Key Players Spine Biologics Revenue (2019-2020) (Million US$)
Table 46. Europe Key Players Spine Biologics Market Share (2019-2020)
Table 47. Europe Spine Biologics Market Size by Type (2015-2020) (Million US$)
Table 48. Europe Spine Biologics Market Share by Type (2015-2020)
Table 49. Europe Spine Biologics Market Size by Application (2015-2020) (Million US$)
Table 50. Europe Spine Biologics Market Share by Application (2015-2020)
Table 51. China Key Players Spine Biologics Revenue (2019-2020) (Million US$)
Table 52. China Key Players Spine Biologics Market Share (2019-2020)
Table 53. China Spine Biologics Market Size by Type (2015-2020) (Million US$)
Table 54. China Spine Biologics Market Share by Type (2015-2020)
Table 55. China Spine Biologics Market Size by Application (2015-2020) (Million US$)
Table 56. China Spine Biologics Market Share by Application (2015-2020)
Table 57. Japan Key Players Spine Biologics Revenue (2019-2020) (Million US$)
Table 58. Japan Key Players Spine Biologics Market Share (2019-2020)
Table 59. Japan Spine Biologics Market Size by Type (2015-2020) (Million US$)
Table 60. Japan Spine Biologics Market Share by Type (2015-2020)
Table 61. Japan Spine Biologics Market Size by Application (2015-2020) (Million US$)
Table 62. Japan Spine Biologics Market Share by Application (2015-2020)
Table 63. Southeast Asia Key Players Spine Biologics Revenue (2019-2020) (Million US$)
Table 64. Southeast Asia Key Players Spine Biologics Market Share (2019-2020)
Table 65. Southeast Asia Spine Biologics Market Size by Type (2015-2020) (Million US$)
Table 66. Southeast Asia Spine Biologics Market Share by Type (2015-2020)
Table 67. Southeast Asia Spine Biologics Market Size by Application (2015-2020) (Million US$)
Table 68. Southeast Asia Spine Biologics Market Share by Application (2015-2020)
Table 69. India Key Players Spine Biologics Revenue (2019-2020) (Million US$)
Table 70. India Key Players Spine Biologics Market Share (2019-2020)
Table 71. India Spine Biologics Market Size by Type (2015-2020) (Million US$)
Table 72. India Spine Biologics Market Share by Type (2015-2020)
Table 73. India Spine Biologics Market Size by Application (2015-2020) (Million US$)
Table 74. India Spine Biologics Market Share by Application (2015-2020)
Table 75. Central & South America Key Players Spine Biologics Revenue (2019-2020) (Million US$)
Table 76. Central & South America Key Players Spine Biologics Market Share (2019-2020)
Table 77. Central & South America Spine Biologics Market Size by Type (2015-2020) (Million US$)
Table 78. Central & South America Spine Biologics Market Share by Type (2015-2020)
Table 79. Central & South America Spine Biologics Market Size by Application (2015-2020) (Million US$)
Table 80. Central & South America Spine Biologics Market Share by Application (2015-2020)
Table 81. Medtronic Company Details
Table 82. Medtronic Business Overview
Table 83. Medtronic Product
Table 84. Medtronic Revenue in Spine Biologics Business (2015-2020) (Million US$)
Table 85. Medtronic Recent Development
Table 86. Depuy Synthes Company Details
Table 87. Depuy Synthes Business Overview
Table 88. Depuy Synthes Product
Table 89. Depuy Synthes Revenue in Spine Biologics Business (2015-2020) (Million US$)
Table 90. Depuy Synthes Recent Development
Table 91. Stryker Corporation Company Details
Table 92. Stryker Corporation Business Overview
Table 93. Stryker Corporation Product
Table 94. Stryker Corporation Revenue in Spine Biologics Business (2015-2020) (Million US$)
Table 95. Stryker Corporation Recent Development
Table 96. Nuvasive Company Details
Table 97. Nuvasive Business Overview
Table 98. Nuvasive Product
Table 99. Nuvasive Revenue in Spine Biologics Business (2015-2020) (Million US$)
Table 100. Nuvasive Recent Development
Table 101. Zimmer Biomet Company Details
Table 102. Zimmer Biomet Business Overview
Table 103. Zimmer Biomet Product
Table 104. Zimmer Biomet Revenue in Spine Biologics Business (2015-2020) (Million US$)
Table 105. Zimmer Biomet Recent Development
Table 106. Orthofix International Company Details
Table 107. Orthofix International Business Overview
Table 108. Orthofix International Product
Table 109. Orthofix International Revenue in Spine Biologics Business (2015-2020) (Million US$)
Table 110. Orthofix International Recent Development
Table 111. Globus Medical Company Details
Table 112. Globus Medical Business Overview
Table 113. Globus Medical Product
Table 114. Globus Medical Revenue in Spine Biologics Business (2015-2020) (Million US$)
Table 115. Globus Medical Recent Development
Table 116. alphatec spine Business Overview
Table 117. alphatec spine Product
Table 118. alphatec spine Company Details
Table 119. alphatec spine Revenue in Spine Biologics Business (2015-2020) (Million US$)
Table 120. alphatec spine Recent Development
Table 121. K2M Company Details
Table 122. K2M Business Overview
Table 123. K2M Product
Table 124. K2M Revenue in Spine Biologics Business (2015-2020) (Million US$)
Table 125. K2M Recent Development
Table 126. Exactech Company Details
Table 127. Exactech Business Overview
Table 128. Exactech Product
Table 129. Exactech Revenue in Spine Biologics Business (2015-2020) (Million US$)
Table 130. Exactech Recent Development
Table 131. Wright Medical Technology Company Details
Table 132. Wright Medical Technology Business Overview
Table 133. Wright Medical Technology Product
Table 134. Wright Medical Technology Revenue in Spine Biologics Business (2015-2020) (Million US$)
Table 135. Wright Medical Technology Recent Development
Table 136. X-Spine Company Details
Table 137. X-Spine Business Overview
Table 138. X-Spine Product
Table 139. X-Spine Revenue in Spine Biologics Business (2015-2020) (Million US$)
Table 140. X-Spine Recent Development
Table 141. Nutech Company Details
Table 142. Nutech Business Overview
Table 143. Nutech Product
Table 144. Nutech Revenue in Spine Biologics Business (2015-2020) (Million US$)
Table 145. Nutech Recent Development
Table 146. Arthrex Company Details
Table 147. Arthrex Business Overview
Table 148. Arthrex Product
Table 149. Arthrex Revenue in Spine Biologics Business (2015-2020) (Million US$)
Table 150. Arthrex Recent Development
Table 151. Research Programs/Design for This Report
Table 152. Key Data Information from Secondary Sources
Table 153. Key Data Information from Primary Sources
LIST OF FIGURES
Figure 1. Global Spine Biologics Market Share by Type: 2020 VS 2026
Figure 2. Bone Graft Features
Figure 3. Bone Graft Substitute Features
Figure 4. Platelet Rich Plasma (PRP) Features
Figure 5. BMAC (Bone Marrow Aspirate Concentrate) Features
Figure 6. Global Spine Biologics Market Share by Application: 2020 VS 2026
Figure 7. Anterior Cervical Discectomy and Fusion Case Studies
Figure 8. Posterior Lumbar Interbody Fusion Case Studies
Figure 9. Other Case Studies
Figure 10. Spine Biologics Report Years Considered
Figure 11. Global Spine Biologics Market Size YoY Growth 2015-2026 (US$ Million)
Figure 12. Global Spine Biologics Market Share by Regions: 2020 VS 2026
Figure 13. Global Spine Biologics Market Share by Regions (2021-2026)
Figure 14. Porter's Five Forces Analysis
Figure 15. Global Spine Biologics Market Share by Players in 2019
Figure 16. Global Top Spine Biologics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Spine Biologics as of 2019
Figure 17. The Top 10 and 5 Players Market Share by Spine Biologics Revenue in 2019
Figure 18. North America Spine Biologics Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Europe Spine Biologics Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. China Spine Biologics Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Japan Spine Biologics Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Southeast Asia Spine Biologics Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. India Spine Biologics Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Central & South America Spine Biologics Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Medtronic Total Revenue (US$ Million): 2019 Compared with 2018
Figure 26. Medtronic Revenue Growth Rate in Spine Biologics Business (2015-2020)
Figure 27. Depuy Synthes Total Revenue (US$ Million): 2019 Compared with 2018
Figure 28. Depuy Synthes Revenue Growth Rate in Spine Biologics Business (2015-2020)
Figure 29. Stryker Corporation Total Revenue (US$ Million): 2019 Compared with 2018
Figure 30. Stryker Corporation Revenue Growth Rate in Spine Biologics Business (2015-2020)
Figure 31. Nuvasive Total Revenue (US$ Million): 2019 Compared with 2018
Figure 32. Nuvasive Revenue Growth Rate in Spine Biologics Business (2015-2020)
Figure 33. Zimmer Biomet Total Revenue (US$ Million): 2019 Compared with 2018
Figure 34. Zimmer Biomet Revenue Growth Rate in Spine Biologics Business (2015-2020)
Figure 35. Orthofix International Total Revenue (US$ Million): 2019 Compared with 2018
Figure 36. Orthofix International Revenue Growth Rate in Spine Biologics Business (2015-2020)
Figure 37. Globus Medical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 38. Globus Medical Revenue Growth Rate in Spine Biologics Business (2015-2020)
Figure 39. alphatec spine Total Revenue (US$ Million): 2019 Compared with 2018
Figure 40. alphatec spine Revenue Growth Rate in Spine Biologics Business (2015-2020)
Figure 41. K2M Total Revenue (US$ Million): 2019 Compared with 2018
Figure 42. K2M Revenue Growth Rate in Spine Biologics Business (2015-2020)
Figure 43. Exactech Total Revenue (US$ Million): 2019 Compared with 2018
Figure 44. Exactech Revenue Growth Rate in Spine Biologics Business (2015-2020)
Figure 45. Wright Medical Technology Total Revenue (US$ Million): 2019 Compared with 2018
Figure 46. Wright Medical Technology Revenue Growth Rate in Spine Biologics Business (2015-2020)
Figure 47. X-Spine Total Revenue (US$ Million): 2019 Compared with 2018
Figure 48. X-Spine Revenue Growth Rate in Spine Biologics Business (2015-2020)
Figure 49. Nutech Total Revenue (US$ Million): 2019 Compared with 2018
Figure 50. Nutech Revenue Growth Rate in Spine Biologics Business (2015-2020)
Figure 51. Arthrex Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. Arthrex Revenue Growth Rate in Spine Biologics Business (2015-2020)
Figure 53. Bottom-up and Top-down Approaches for This Report
Figure 54. Data Triangulation
Figure 55. Key Executives Interviewed
Figure 1. Global Spine Biologics Market Share by Type: 2020 VS 2026
Figure 2. Bone Graft Features
Figure 3. Bone Graft Substitute Features
Figure 4. Platelet Rich Plasma (PRP) Features
Figure 5. BMAC (Bone Marrow Aspirate Concentrate) Features
Figure 6. Global Spine Biologics Market Share by Application: 2020 VS 2026
Figure 7. Anterior Cervical Discectomy and Fusion Case Studies
Figure 8. Posterior Lumbar Interbody Fusion Case Studies
Figure 9. Other Case Studies
Figure 10. Spine Biologics Report Years Considered
Figure 11. Global Spine Biologics Market Size YoY Growth 2015-2026 (US$ Million)
Figure 12. Global Spine Biologics Market Share by Regions: 2020 VS 2026
Figure 13. Global Spine Biologics Market Share by Regions (2021-2026)
Figure 14. Porter's Five Forces Analysis
Figure 15. Global Spine Biologics Market Share by Players in 2019
Figure 16. Global Top Spine Biologics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Spine Biologics as of 2019
Figure 17. The Top 10 and 5 Players Market Share by Spine Biologics Revenue in 2019
Figure 18. North America Spine Biologics Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Europe Spine Biologics Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. China Spine Biologics Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Japan Spine Biologics Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Southeast Asia Spine Biologics Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. India Spine Biologics Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Central & South America Spine Biologics Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Medtronic Total Revenue (US$ Million): 2019 Compared with 2018
Figure 26. Medtronic Revenue Growth Rate in Spine Biologics Business (2015-2020)
Figure 27. Depuy Synthes Total Revenue (US$ Million): 2019 Compared with 2018
Figure 28. Depuy Synthes Revenue Growth Rate in Spine Biologics Business (2015-2020)
Figure 29. Stryker Corporation Total Revenue (US$ Million): 2019 Compared with 2018
Figure 30. Stryker Corporation Revenue Growth Rate in Spine Biologics Business (2015-2020)
Figure 31. Nuvasive Total Revenue (US$ Million): 2019 Compared with 2018
Figure 32. Nuvasive Revenue Growth Rate in Spine Biologics Business (2015-2020)
Figure 33. Zimmer Biomet Total Revenue (US$ Million): 2019 Compared with 2018
Figure 34. Zimmer Biomet Revenue Growth Rate in Spine Biologics Business (2015-2020)
Figure 35. Orthofix International Total Revenue (US$ Million): 2019 Compared with 2018
Figure 36. Orthofix International Revenue Growth Rate in Spine Biologics Business (2015-2020)
Figure 37. Globus Medical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 38. Globus Medical Revenue Growth Rate in Spine Biologics Business (2015-2020)
Figure 39. alphatec spine Total Revenue (US$ Million): 2019 Compared with 2018
Figure 40. alphatec spine Revenue Growth Rate in Spine Biologics Business (2015-2020)
Figure 41. K2M Total Revenue (US$ Million): 2019 Compared with 2018
Figure 42. K2M Revenue Growth Rate in Spine Biologics Business (2015-2020)
Figure 43. Exactech Total Revenue (US$ Million): 2019 Compared with 2018
Figure 44. Exactech Revenue Growth Rate in Spine Biologics Business (2015-2020)
Figure 45. Wright Medical Technology Total Revenue (US$ Million): 2019 Compared with 2018
Figure 46. Wright Medical Technology Revenue Growth Rate in Spine Biologics Business (2015-2020)
Figure 47. X-Spine Total Revenue (US$ Million): 2019 Compared with 2018
Figure 48. X-Spine Revenue Growth Rate in Spine Biologics Business (2015-2020)
Figure 49. Nutech Total Revenue (US$ Million): 2019 Compared with 2018
Figure 50. Nutech Revenue Growth Rate in Spine Biologics Business (2015-2020)
Figure 51. Arthrex Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. Arthrex Revenue Growth Rate in Spine Biologics Business (2015-2020)
Figure 53. Bottom-up and Top-down Approaches for This Report
Figure 54. Data Triangulation
Figure 55. Key Executives Interviewed
